Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.
Identifieur interne : 000381 ( Main/Exploration ); précédent : 000380; suivant : 000382Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.
Auteurs : Mark Hamer [Royaume-Uni] ; Catharine R. Gale [Royaume-Uni] ; Mika Kivim Ki [Royaume-Uni] ; G David Batty [Royaume-Uni]Source :
- Proceedings of the National Academy of Sciences of the United States of America [ 1091-6490 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Betacoronavirus (MeSH), Facteurs de risque (MeSH), Femelle (MeSH), Hospitalisation (MeSH), Humains (MeSH), Indice de masse corporelle (MeSH), Infections à coronavirus (complications), Mâle (MeSH), Obésité (complications), Pandémies (MeSH), Pneumopathie virale (complications), Population d'origine européenne (MeSH), Royaume-Uni (MeSH), Sujet âgé (MeSH), Surpoids (complications), Études de cohortes (MeSH).
- MESH :
- Wicri :
- geographic : Royaume-Uni.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Betacoronavirus (MeSH), Body Mass Index (MeSH), Cohort Studies (MeSH), Coronavirus Infections (complications), European Continental Ancestry Group (MeSH), Female (MeSH), Hospitalization (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Obesity (complications), Overweight (complications), Pandemics (MeSH), Pneumonia, Viral (complications), Risk Factors (MeSH), United Kingdom (MeSH).
- MESH :
- geographic : United Kingdom.
- complications : Coronavirus Infections, Obesity, Overweight, Pneumonia, Viral.
- Adult, Aged, Betacoronavirus, Body Mass Index, Cohort Studies, European Continental Ancestry Group, Female, Hospitalization, Humans, Male, Middle Aged, Pandemics, Risk Factors.
Abstract
The role of obesity and overweight in occurrence of COVID-19 is unknown. We conducted a large-scale general population study using data from a community-dwelling sample in England (n = 334,329; 56.4 ±8.1 y; 54.5% women) with prospective linkage to national registry on hospitalization for COVID-19. Body mass index (BMI, from measured height and weight) was used as an indicator of overall obesity, and waist-hip ratio for central obesity. Main outcome was cases of COVID-19 serious enough to warrant a hospital admission from 16 March 2020 to 26 April 2020. Around 0.2% (n = 640) of the sample were hospitalized for COVID-19. There was an upward linear trend in the likelihood of COVID-19 hospitalization with increasing BMI, that was evident in the overweight (odds ratio, 1.39; 95% CI 1.13 to 1.71; crude incidence 19.1 per 10,000) and obese stage I (1.70;1.34 to 2.16; 23.3 per 10,000) and stage II (3.38; 2.60 to 4.40; 42.7 per 10,000) compared to normal weight (12.5 per 10,000). This gradient was little affected after adjustment for a wide range of covariates; however, controlling for biomarkers, particularly high-density lipoprotein cholesterol and glycated hemoglobin, led to a greater degree of attenuation. A similar pattern of association emerged for waist-hip ratio. In summary, overall and central obesity are risk factors for COVID-19 hospital admission. Elevated risk was apparent even at modest weight gain. The mechanisms may involve impaired glucose and lipid metabolism.
DOI: 10.1073/pnas.2011086117
PubMed: 32788355
PubMed Central: PMC7474583
Affiliations:
- Royaume-Uni
- Angleterre, Grand Londres, Écosse
- Londres, Édimbourg
- University College de Londres, Université d'Édimbourg
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.</title><author><name sortKey="Hamer, Mark" sort="Hamer, Mark" uniqKey="Hamer M" first="Mark" last="Hamer">Mark Hamer</name><affiliation wicri:level="4"><nlm:affiliation>Division of Surgery and Interventional Science, Faculty Medical Sciences, University College London, London WC1E 6BT, United Kingdom; m.hamer@ucl.ac.uk.</nlm:affiliation><country wicri:rule="url">Royaume-Uni</country><wicri:regionArea>Division of Surgery and Interventional Science, Faculty Medical Sciences, University College London, London WC1E 6BT</wicri:regionArea><orgName type="university">University College de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Gale, Catharine R" sort="Gale, Catharine R" uniqKey="Gale C" first="Catharine R" last="Gale">Catharine R. Gale</name><affiliation wicri:level="1"><nlm:affiliation>Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD</wicri:regionArea><wicri:noRegion>Southampton SO16 6YD</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ</wicri:regionArea><orgName type="university">Université d'Édimbourg</orgName><placeName><settlement type="city">Édimbourg</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Kivim Ki, Mika" sort="Kivim Ki, Mika" uniqKey="Kivim Ki M" first="Mika" last="Kivim Ki">Mika Kivim Ki</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Epidemiology and Public Health, University College London, London WC1E 6BT</wicri:regionArea><orgName type="university">University College de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Batty, G David" sort="Batty, G David" uniqKey="Batty G" first="G David" last="Batty">G David Batty</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Epidemiology and Public Health, University College London, London WC1E 6BT</wicri:regionArea><orgName type="university">University College de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32788355</idno><idno type="pmid">32788355</idno><idno type="doi">10.1073/pnas.2011086117</idno><idno type="pmc">PMC7474583</idno><idno type="wicri:Area/Main/Corpus">000687</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000687</idno><idno type="wicri:Area/Main/Curation">000687</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000687</idno><idno type="wicri:Area/Main/Exploration">000687</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.</title><author><name sortKey="Hamer, Mark" sort="Hamer, Mark" uniqKey="Hamer M" first="Mark" last="Hamer">Mark Hamer</name><affiliation wicri:level="4"><nlm:affiliation>Division of Surgery and Interventional Science, Faculty Medical Sciences, University College London, London WC1E 6BT, United Kingdom; m.hamer@ucl.ac.uk.</nlm:affiliation><country wicri:rule="url">Royaume-Uni</country><wicri:regionArea>Division of Surgery and Interventional Science, Faculty Medical Sciences, University College London, London WC1E 6BT</wicri:regionArea><orgName type="university">University College de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Gale, Catharine R" sort="Gale, Catharine R" uniqKey="Gale C" first="Catharine R" last="Gale">Catharine R. Gale</name><affiliation wicri:level="1"><nlm:affiliation>Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD</wicri:regionArea><wicri:noRegion>Southampton SO16 6YD</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ</wicri:regionArea><orgName type="university">Université d'Édimbourg</orgName><placeName><settlement type="city">Édimbourg</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Kivim Ki, Mika" sort="Kivim Ki, Mika" uniqKey="Kivim Ki M" first="Mika" last="Kivim Ki">Mika Kivim Ki</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Epidemiology and Public Health, University College London, London WC1E 6BT</wicri:regionArea><orgName type="university">University College de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Batty, G David" sort="Batty, G David" uniqKey="Batty G" first="G David" last="Batty">G David Batty</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Epidemiology and Public Health, University College London, London WC1E 6BT</wicri:regionArea><orgName type="university">University College de Londres</orgName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title><idno type="eISSN">1091-6490</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Body Mass Index (MeSH)</term><term>Cohort Studies (MeSH)</term><term>Coronavirus Infections (complications)</term><term>European Continental Ancestry Group (MeSH)</term><term>Female (MeSH)</term><term>Hospitalization (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Obesity (complications)</term><term>Overweight (complications)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Risk Factors (MeSH)</term><term>United Kingdom (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Femelle (MeSH)</term><term>Hospitalisation (MeSH)</term><term>Humains (MeSH)</term><term>Indice de masse corporelle (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Mâle (MeSH)</term><term>Obésité (complications)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Population d'origine européenne (MeSH)</term><term>Royaume-Uni (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Surpoids (complications)</term><term>Études de cohortes (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>United Kingdom</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Obesity</term><term>Overweight</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Betacoronavirus</term><term>Body Mass Index</term><term>Cohort Studies</term><term>European Continental Ancestry Group</term><term>Female</term><term>Hospitalization</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Betacoronavirus</term><term>Facteurs de risque</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Indice de masse corporelle</term><term>Infections à coronavirus</term><term>Mâle</term><term>Obésité</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Population d'origine européenne</term><term>Royaume-Uni</term><term>Sujet âgé</term><term>Surpoids</term><term>Études de cohortes</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Royaume-Uni</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The role of obesity and overweight in occurrence of COVID-19 is unknown. We conducted a large-scale general population study using data from a community-dwelling sample in England (<i>n</i> = 334,329; 56.4 ±8.1 y; 54.5% women) with prospective linkage to national registry on hospitalization for COVID-19. Body mass index (BMI, from measured height and weight) was used as an indicator of overall obesity, and waist-hip ratio for central obesity. Main outcome was cases of COVID-19 serious enough to warrant a hospital admission from 16 March 2020 to 26 April 2020. Around 0.2% (<i>n</i> = 640) of the sample were hospitalized for COVID-19. There was an upward linear trend in the likelihood of COVID-19 hospitalization with increasing BMI, that was evident in the overweight (odds ratio, 1.39; 95% CI 1.13 to 1.71; crude incidence 19.1 per 10,000) and obese stage I (1.70;1.34 to 2.16; 23.3 per 10,000) and stage II (3.38; 2.60 to 4.40; 42.7 per 10,000) compared to normal weight (12.5 per 10,000). This gradient was little affected after adjustment for a wide range of covariates; however, controlling for biomarkers, particularly high-density lipoprotein cholesterol and glycated hemoglobin, led to a greater degree of attenuation. A similar pattern of association emerged for waist-hip ratio. In summary, overall and central obesity are risk factors for COVID-19 hospital admission. Elevated risk was apparent even at modest weight gain. The mechanisms may involve impaired glucose and lipid metabolism.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32788355</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>35</Issue><PubDate><Year>2020</Year><Month>09</Month><Day>01</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.</ArticleTitle><Pagination><MedlinePgn>21011-21013</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2011086117</ELocationID><Abstract><AbstractText>The role of obesity and overweight in occurrence of COVID-19 is unknown. We conducted a large-scale general population study using data from a community-dwelling sample in England (<i>n</i> = 334,329; 56.4 ±8.1 y; 54.5% women) with prospective linkage to national registry on hospitalization for COVID-19. Body mass index (BMI, from measured height and weight) was used as an indicator of overall obesity, and waist-hip ratio for central obesity. Main outcome was cases of COVID-19 serious enough to warrant a hospital admission from 16 March 2020 to 26 April 2020. Around 0.2% (<i>n</i> = 640) of the sample were hospitalized for COVID-19. There was an upward linear trend in the likelihood of COVID-19 hospitalization with increasing BMI, that was evident in the overweight (odds ratio, 1.39; 95% CI 1.13 to 1.71; crude incidence 19.1 per 10,000) and obese stage I (1.70;1.34 to 2.16; 23.3 per 10,000) and stage II (3.38; 2.60 to 4.40; 42.7 per 10,000) compared to normal weight (12.5 per 10,000). This gradient was little affected after adjustment for a wide range of covariates; however, controlling for biomarkers, particularly high-density lipoprotein cholesterol and glycated hemoglobin, led to a greater degree of attenuation. A similar pattern of association emerged for waist-hip ratio. In summary, overall and central obesity are risk factors for COVID-19 hospital admission. Elevated risk was apparent even at modest weight gain. The mechanisms may involve impaired glucose and lipid metabolism.</AbstractText><CopyrightInformation>Copyright © 2020 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamer</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8726-7992</Identifier><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science, Faculty Medical Sciences, University College London, London WC1E 6BT, United Kingdom; m.hamer@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gale</LastName><ForeName>Catharine R</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0002-3361-8638</Identifier><AffiliationInfo><Affiliation>Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kivimäki</LastName><ForeName>Mika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batty</LastName><ForeName>G David</ForeName><Initials>GD</Initials><Identifier Source="ORCID">0000-0003-1822-5753</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG052519</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01AG052519-01A1</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R56AG052519-01</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG052519</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG056477</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">epidemiology</Keyword><Keyword MajorTopicYN="Y">infection</Keyword><Keyword MajorTopicYN="Y">obesity</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32788355</ArticleId><ArticleId IdType="pii">2011086117</ArticleId><ArticleId IdType="doi">10.1073/pnas.2011086117</ArticleId><ArticleId IdType="pmc">PMC7474583</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Intern Med. 2000 Nov 13;160(20):3082-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11074737</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2019 Feb 5;92(6):e594-e600</Citation><ArticleIdList><ArticleId IdType="pubmed">30626649</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2016 Jun 1;183(11):1008-17</Citation><ArticleIdList><ArticleId IdType="pubmed">27188940</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 2019 Jun;123:65-70</Citation><ArticleIdList><ArticleId IdType="pubmed">30844499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Epidemiol. 2007 Nov;17(6):194-202</Citation><ArticleIdList><ArticleId IdType="pubmed">18094518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564</Citation><ArticleIdList><ArticleId IdType="pubmed">32437642</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Feb 12;368:m131</Citation><ArticleIdList><ArticleId IdType="pubmed">32051121</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):896-897</Citation><ArticleIdList><ArticleId IdType="pubmed">32271368</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2020 Jul;87:184-187</Citation><ArticleIdList><ArticleId IdType="pubmed">32454138</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2016 Apr;101(4):1680-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26863425</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2011 Jan;15(1):e54-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21095152</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2015 Nov;58(11):2596-605</Citation><ArticleIdList><ArticleId IdType="pubmed">26290049</ArticleId></ArticleIdList></Reference><Reference><Citation>Obesity (Silver Spring). 2020 Jul;28(7):1195-1199</Citation><ArticleIdList><ArticleId IdType="pubmed">32271993</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2013 Jul;42(1):180-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23222873</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2015 Mar 31;12(3):e1001779</Citation><ArticleIdList><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Écosse</li></region><settlement><li>Londres</li><li>Édimbourg</li></settlement><orgName><li>University College de Londres</li><li>Université d'Édimbourg</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Hamer, Mark" sort="Hamer, Mark" uniqKey="Hamer M" first="Mark" last="Hamer">Mark Hamer</name></region><name sortKey="Batty, G David" sort="Batty, G David" uniqKey="Batty G" first="G David" last="Batty">G David Batty</name><name sortKey="Gale, Catharine R" sort="Gale, Catharine R" uniqKey="Gale C" first="Catharine R" last="Gale">Catharine R. Gale</name><name sortKey="Gale, Catharine R" sort="Gale, Catharine R" uniqKey="Gale C" first="Catharine R" last="Gale">Catharine R. Gale</name><name sortKey="Kivim Ki, Mika" sort="Kivim Ki, Mika" uniqKey="Kivim Ki M" first="Mika" last="Kivim Ki">Mika Kivim Ki</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000381 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000381 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32788355
|texte= Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32788355" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |